CTAS vs VERO · P/E 51, rev $11.26B vs rev $64.8M
Cintas Corporation (CTAS) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. VERO currently screens at market cap $578.2K.
Not investment advice. Open the CTAS and VERO stock pages for the full models.
Not investment advice.